FolioLanternBeta
MEDPMedpace Holdings, Inc.

August Troendle

President & CEO, Director at Medpace Holdings, Inc., as of Oct 1, 2026Sold $358M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
10%
share of stake sold at Medpace Holdings, Inc.
5.07M
shares held after the latest filing, Medpace Holdings, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $150M no plan disclosed$150MNovDec 2025: $17.5M no plan disclosedDecJanFebMarAprMayJunJul 2026: $4.3M no plan disclosedJulAug 2026: $60.6M no plan disclosedAugSep 2026: $126M no plan disclosedSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Medpace Holdings, Inc. (MEDP)President & CEO, DirectorAug 10, 2016Oct 1, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.